AAP guidance recommends genetic testing for GDD/IDs, leading to a GeneDx stock surge and a price target raise by Jefferies Financial Group.
2 reports, 0 independent
Updated Jun 27
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AAP guidance recommends genetic testing for GDD/IDs, leading to a GeneDx stock surge and a price target raise by Jefferies Financial Group.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GeneDx
company in Stamford, United States
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet